Format
Items per page
Sort by

Send to:

Choose Destination

Results: 13

Cited In for PubMed (Select 19124725)

1.

Soluble amyloid triggers a myeloid differentiation factor 88 and interferon regulatory factor 7 dependent neuronal type-1 interferon response in vitro.

Minter MR, Main BS, Brody KM, Zhang M, Taylor JM, Crack PJ.

J Neuroinflammation. 2015 Apr 12;12:71. doi: 10.1186/s12974-015-0263-2.

2.

Type I interferon signaling contributes to the bias that Toll-like receptor 4 exhibits for signaling mediated by the adaptor protein TRIF.

Kolb JP, Casella CR, SenGupta S, Chilton PM, Mitchell TC.

Sci Signal. 2014 Nov 11;7(351):ra108. doi: 10.1126/scisignal.2005442.

3.

Interferon regulatory factor 5-dependent immune responses in the draining lymph node protect against West Nile virus infection.

Thackray LB, Shrestha B, Richner JM, Miner JJ, Pinto AK, Lazear HM, Gale M Jr, Diamond MS.

J Virol. 2014 Oct;88(19):11007-21. doi: 10.1128/JVI.01545-14. Epub 2014 Jul 16.

4.

The SLE transcriptome exhibits evidence of chronic endotoxin exposure and has widespread dysregulation of non-coding and coding RNAs.

Shi L, Zhang Z, Yu AM, Wang W, Wei Z, Akhter E, Maurer K, Costa Reis P, Song L, Petri M, Sullivan KE.

PLoS One. 2014 May 5;9(5):e93846. doi: 10.1371/journal.pone.0093846. eCollection 2014.

5.

Phenotype and function of B cells and dendritic cells from interferon regulatory factor 5-deficient mice with and without a mutation in DOCK2.

Yasuda K, NĂ¼ndel K, Watkins AA, Dhawan T, Bonegio RG, Ubellacker JM, Marshak-Rothstein A, Rifkin IR.

Int Immunol. 2013 May;25(5):295-306. doi: 10.1093/intimm/dxs114. Epub 2013 Jan 4.

6.

Oncogenic IRFs provide a survival advantage for Epstein-Barr virus- or human T-cell leukemia virus type 1-transformed cells through induction of BIC expression.

Wang L, Toomey NL, Diaz LA, Walker G, Ramos JC, Barber GN, Ning S.

J Virol. 2011 Aug;85(16):8328-37. doi: 10.1128/JVI.00570-11. Epub 2011 Jun 15.

7.

IRF7: activation, regulation, modification and function.

Ning S, Pagano JS, Barber GN.

Genes Immun. 2011 Sep;12(6):399-414. doi: 10.1038/gene.2011.21. Epub 2011 Apr 14. Review.

8.

Measure and countermeasure: type I IFN (IFN-alpha/beta) antiviral response against West Nile virus.

Daffis S, Suthar MS, Gale M Jr, Diamond MS.

J Innate Immun. 2009;1(5):435-45. doi: 10.1159/000226248. Epub 2009 Jun 24. Review.

9.

Dendritic cells in systemic lupus erythematosus.

Seitz HM, Matsushima GK.

Int Rev Immunol. 2010 Apr;29(2):184-209. doi: 10.3109/08830181003602507. Review.

10.

IFN regulatory factor 5 is required for disease development in the FcgammaRIIB-/-Yaa and FcgammaRIIB-/- mouse models of systemic lupus erythematosus.

Richez C, Yasuda K, Bonegio RG, Watkins AA, Aprahamian T, Busto P, Richards RJ, Liu CL, Cheung R, Utz PJ, Marshak-Rothstein A, Rifkin IR.

J Immunol. 2010 Jan 15;184(2):796-806. doi: 10.4049/jimmunol.0901748. Epub 2009 Dec 9.

11.

Induction of IFN-beta and the innate antiviral response in myeloid cells occurs through an IPS-1-dependent signal that does not require IRF-3 and IRF-7.

Daffis S, Suthar MS, Szretter KJ, Gale M Jr, Diamond MS.

PLoS Pathog. 2009 Oct;5(10):e1000607. doi: 10.1371/journal.ppat.1000607. Epub 2009 Oct 2.

12.

Effects of Lansoprazole on the Lipopolysaccharide-Stimulated Toll-Like Receptor 4 Signal Transduction Systems: A Study Using the 293hTLR4/MD2-CD14 Cells.

Ohara T, Kanoh Y, Yoshino K, Kitajima M.

J Clin Biochem Nutr. 2009 Sep;45(2):241-7. doi: 10.3164/jcbn.09-42. Epub 2009 Aug 28.

13.

Deconvolution of blood microarray data identifies cellular activation patterns in systemic lupus erythematosus.

Abbas AR, Wolslegel K, Seshasayee D, Modrusan Z, Clark HF.

PLoS One. 2009 Jul 1;4(7):e6098. doi: 10.1371/journal.pone.0006098.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk